Skip to main content
Premium Trial:

Request an Annual Quote

Centogene Single Gene Analysis and NGS Panel Expansion

Centogene has expanded its single gene tests and next-generation sequencing panel portfolio to include over 100 more genes. The expansion includes genes linked with metabolic diseases, ophthalmological diseases, cardiological and lung diseases, vascular diseases, immune diseases, endocrinological disease, malformation and retardation syndromes, and neurological diseases. The full list of new single gene tests and next-generation sequencing panels can be found here.